PRospective Prostate biOmarker Study
NCT03565289 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 455
Last updated 2020-12-16
Summary
• Correlation of a glycoprotein panel with prostate biopsy outcome and PCa aggressiveness
Conditions
- Indication for Prostate Biopsy Due to Suspected Prostate Cancer
Interventions
- DIAGNOSTIC_TEST
-
Blood sample collection
During a routine blood draw an additional tube of blood will be taken for the study.
Sponsors & Collaborators
-
ProteoMediX AG
lead INDUSTRY
Principal Investigators
-
Thomas Steuber, Prof. Dr. · Martiniklinik am UKE gGmbH
Eligibility
- Min Age
- 45 Years
- Max Age
- 80 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-14
- Primary Completion
- 2019-12-31
- Completion
- 2020-01-31
Countries
- Austria
- Denmark
- Germany
Study Locations
More Related Trials
-
PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer
NCT02735252 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients
NCT03237026 ·Status: RECRUITING
-
PRO-STATE:Search for a Protein Profile Corresponding to Fast-developing Lesions and Characterization of Implicated Proteins in Prostate Carcinoma
NCT00427817 ·Status: COMPLETED
-
Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
NCT07131956 ·Status: RECRUITING
-
Application of a Novel Biomarker Based on Plasma cfDNA Assay in the Early Diagnosis of Prostate Cancer
NCT06509919 ·Status: RECRUITING
-
EMBRACE1: Prostate Biorepository
NCT01499381 ·Status: COMPLETED
-
Markers for Early Detection of Prostate Cancer
NCT00340717 ·Status: COMPLETED
-
Multicentric Comparative Prospective Study of the Benefits and Risks of Biopsy Prostate Using Transrectal or Transperineal Procedure for the Prostate Cancer Diagnostic
NCT05763355 ·Status: COMPLETED ·Phase: NA
-
Effects of a New Diagnostic Test on the Care of Prostate Cancer Patients: The ProMark™ Clinical Utility Study
NCT04550416 ·Status: COMPLETED ·Phase: NA
-
A Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3
NCT06507462 ·Status: COMPLETED
-
Prospective Evaluation of Proclarix® Test to Improve Risk Stratification in Men Scheduled for MpMRI and Prostate Biopsy in Cantonal Hospital Aarau
NCT06637267 ·Status: RECRUITING
-
the Beijing Randomized Study Of Prostate Cancer Screening
NCT05961514 ·Status: UNKNOWN ·Phase: NA
-
Predicting Prostate Biopsy Results With Biomarkers and mpMRI.
NCT03730324 ·Status: COMPLETED ·Phase: NA
-
Non-Invasive Biomarkers in Prostate Cancer Disease Management
NCT06144619 ·Status: SUSPENDED
-
Validation of the Prostate Cancer Assay - Beta+Pivotal
NCT02742259 ·Status: WITHDRAWN
-
Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants
NCT04964271 ·Status: ACTIVE_NOT_RECRUITING
-
The BIOPRES Trial: Transrectal BIOpsies of the PRostate: End Versus Side-firing
NCT00851292 ·Status: UNKNOWN ·Phase: PHASE3
-
The ProCaRis Study: Prostate Cancer Risk Assessment in General Practice
NCT01739062 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prostate Active Surveillance Study
NCT00756665 ·Status: RECRUITING
-
Integrated Genomic Prostate Score With MRI Targeted Prostate Biopsies
NCT04541030 ·Status: ACTIVE_NOT_RECRUITING
-
Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Combination of PSA/DRE and Multi Parametric Magnetic Resonance Imaging
NCT04993508 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Impact of Exercise on Prognostic Biomarkers Related to Prostate Cancer
NCT03397030 ·Status: COMPLETED ·Phase: NA
-
Detection of Micrometastases in Lymph Nodes of Patients With Prostate Cancer
NCT01615965 ·Status: UNKNOWN ·Phase: NA
-
Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer
NCT04702633 ·Status: COMPLETED
-
Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma
NCT00400894 ·Status: UNKNOWN